Tianjin Ringpu Bio-Technology Co.,Ltd. (SHE:300119)
China · Delayed Price · Currency is CNY 18.14
+0.10 (0.55%)
Apr 29, 2026, 3:04 PM CST
SHE:300119 Revenue
In the year 2025, Tianjin Ringpu Bio-Technology had annual revenue of 3.40B CNY with 10.70% growth. Tianjin Ringpu Bio-Technology had revenue of 854.13M in the quarter ending December 31, 2025, with 3.12% growth.
Revenue
3.40B
Revenue Growth
+10.70%
P/S Ratio
2.41
Revenue / Employee
1.21M
Employees
2,900
Market Cap
8.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.40B | 328.53M | 10.70% |
| Dec 31, 2024 | 3.07B | 360.83M | 13.32% |
| Dec 31, 2023 | 2.71B | 624.85M | 29.98% |
| Jan 1, 2023 | 2.08B | 77.11M | 3.84% |
| Jan 1, 2022 | 2.01B | 6.73M | 0.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chongqing Taiji Industry(Group) Co.,Ltd | 10.50B |
| Shandong Lukang Pharmaceutical | 5.71B |
| Renhe Pharmacy Co.,Ltd | 3.68B |
| Jiangsu Kanion Pharmaceutical | 3.29B |
| Jiuzhitang | 2.23B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 2.12B |
| Guilin Sanjin Pharmaceutical | 2.08B |
| Guangxi Wuzhou Zhongheng Group | 1.75B |